1.Introduction
In late December 2019, an outbreak of a mysterious pneumonia characterized by fever, dry cough, and fatigue, and occasional gastrointestinal symptoms happened in a seafood wholesale wet market, the Huanan Seafood Wholesale Market, in Wuhan, Hubei, China. 1 The initial outbreak was reported in the market in December, 2019 and involved about 66% of the staff there. The market was shut down on Jan. 1, 2020, after the announcement of an epidemiological alert by the local health authority on Dec. 31, 2019. However, in the following month (Jan.) thousands of people in China, including many provinces, (such as Hubei, Zhejiang, Guangdong, Henan, Hunan etc.) and cities (Beijing and Shanghai) were attacked by the rampant spreading of the diseases. 2 Furthermore, the disease was exported to other countries, such as Thailand, Japan, Republic of Korea, Viet Nam, Germany, USA, and Singapore. The first case reported in our country was on Jan 23, 2019. As of Feb. 6, 2020, a total of 28276 confirmed cases with 565 deaths globally were documented by WHO, involving at least 25 countries. 3 The pathogen of the outbreak was later identified as a novel betacoronavirus, named 2019 novel coronavirus (2019-nCoV) and recalled to our mind the terrible memory of seventeen years ago-the severe acute respiratory syndrome (SARS-2003, caused by another beta-coronavirus).
In 2003, a new coronavirus, the etiology of a mysterious pneumonia, also originated from southeast China, especially Guangdong province, and was named SARS coronavirus that fulfilled the Koch's postulate. 4 The mortality rate caused by the virus was around 10-15%. 5, 6 Through the years the medical facilities have been improved, nevertheless, no proper treatment or vaccine is available for the SARS. 6 The emergence of another outbreak in 2012 of novel coronavirus in Middle East shared similar features with the outbreak in 2003. 7 Both were caused by coronavirus but the intermediate host for MERS is thought to be the dromedary camel and the mortality can be up to 37%. 5
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The initial clinical manifestations for both SARS and MERS are usually nonspecific except the majority of patients presented with fever and respiratory symptoms.
Unprotected hospital staff that exposed to patients' droplets or through contact prone to be infected and nosocomial infections ensue. 1, 6 Furthermore, cases associated with travel had been identified for SARS, MERS, and 2019-nCoV. (5, (8) (9) (10) (11) Because of global transportation and the popularity of tourism, 2019-nCoV is a genuine threat to Taiwan.
2.Virology
Coronavirus virus is an enveloped, negative single strand RNA virus. It belongs to the Orthocoronavirinae subfamily, as the name, with the characteristic "crown-like" spikes on their surfaces. 5 Together with SARS-CoV, bat SARS-like CoV, and others, they fall into the genus beta-coronavirus. The SSCP (caused by 2019-nCoV infection)
is classified as a fifth-category notifiable communicable disease in Taiwan on Jan. 15, 2019. 12 The genus beta-coronavirus can be divided into several subgroups. The 2019-nCoV, SARS-CoV and bat SARS-like CoV belong to Sarbecovirus, while the MERS-CoV Merbecovirus. 13 SARS-CoV, MERS-CoV, and 2019-nCoV all cause diseases in humans but each subgroup may have mild different biologic characteristic and virulence. [5] [6] [7] The exact origin, location, and natural reservoir of the 2019-nCoV remain unclear, although it is believed that the virus is zoonotic and bats may be the culprits because of sequence identity to the bat-CoV. 5, 13 According to previous studies on the SARS-and MERS-CoV, epidemiological investigations, their natural reservoir is bat while palm civet or raccoon dog may be the intermediate (or susceptible) host for SARS-CoV and the dromedary camel for MERS-CoV. 5, 13 A field study for the SARS-CoV on palm civet ruled out the possibility as the natural reservoir (low positive rate), instead, the prevalence of bat coronavirus among wild life is high and it share a certain A C C E P T E D sequence identity with the human SARS-CoV. 14 Therefore, bats are considered the natural host reservoir of SARS-like coronavirus. 13 However, the origin or natural host for the 2019-nCoV is not clear, although it might come from a kind of wild life in the wet market. 1 Theoretically, if people contact or eat the reservoir or infected animal, they could be infected. However, to result in large scaled person-to-person transmission as in the past SARS outbreak, the virus must spread efficiently. Initially, the 2019-CoV outbreak was reported as limited person-to-person transmission and a contaminated source from infected or sick wild animals in the wet market may be the common origin. 1,2 But more and more evidences came out with clusters of outbreaks among family confirmed the possibility of person-to-person transmission. 8, 10, 11, 15, 16 In addition, the involvement of human angiotensin-converting enzyme 2 (hACE2) as the cellular receptor (like SARS) made droplet transmission to the lower respiratory tract possible. 5, 17 Furthermore, contact transmission like SARS is also likely although the survival time in the environment for the 2019-nCoV is not clear at present. Currently, there was no evidence of air-borne transmission. Viral RNAs could be found in nasal discharge, sputum, and sometimes blood or feces. 1, 9, 10, 13, 15 But can oral-fecal transmission happen has not yet been confirmed. Once people are infected by the 2019-nCoV, it is believed that, like SARS, there is no infectivity until the onset of symptoms. 15 However, one report describes infection from an asymptomatic contact but the investigation was not solid. 10 The infectious doses for 2019-nCoV is not clear but high viral load up to 10 8 copies/mL in patient's sputum has been reported. 10 The viral load increases initially and still can be detected 12 days after onset of symptoms. 9 Therefore, the infectivity of patients with 2019-nCoV may last for about 2 weeks.
However, if infectious viral particles from patients do exist at the later stage requires validation.
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3.Epidemiology (Table 1)
The illness onset of the first laboratory-confirmed case of 2019-nCoV infection was on Dec. 1, 2019 in Wuhan, China. 1 Initially, an outbreak involving a local market, the Huanan Seafood Market, with at least 41 people was reported. 1 The local health authority issued an 'epidemiological alert' on Dec. 31, 2019 and the market was shut down on Jan 1, 2020. A total of 59 suspected cases with fever and dry cough were referred to a designated hospital (the Jin Yin-tan Hospital). Of the 59 suspected cases, forty-one patients were confirmed by next-generation sequencing or real-time RT-PCR.
Twenty-seven (66%, 27/41) patients had history of Huanan Seafood Market exposure. 1 However, there is a caveat that the first case on Dec. 1 did not show history of Huanan Seafood Market exposure and the subsequent cases started on Dec. 10, nine day later.
In the following days, a burst of cases was spreading from Wuhan to the whole Hubei province. Subsequently, many cities and provinces were attacked by this virus. One of the reasons may be due to the heavy transportation load during the Chinese Lunar New
Year (on Jan 25) period. The first exported case was into Thailand on Jan. 13, 2020.
However, the disease spread rapidly and globally. Not only familial clusters but also outbreaks in ocean liners were reported. As of Feb. 6, 2020, a total of 28,276 confirmed cases with 565 deaths globally were documented by WHO, involving at least 25 countries. 3 The WHO issued an public health emergencies of international concern (PHEIC) alarm on Jan 30, 2020. Many stringent quarantine procedures and fever surveillance were underway. The initial mortality rates for patients in the hospital were estimated to be 11-15%, 1,15 but more recent data were 2-3%. It is very likely that personto-person transmissions occur via droplets and contact. Nosocomial infections in the healthcare facilities did happen and stress the importance of good infection control.
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4.Clinical Manifestations
SSCP has a mean incubation period of 5.2 days (95% confidence interval, 4.1-7.0). 16 The infection is acute without any carrier status. Symptoms usually begin with nonspecific syndromes, including fever, dry cough, and fatigue. Multiple systems may be involved, including respiratory (cough, short of breath, sore throat, rhinorrhea, , hemoptysis, and chest pain), gastrointestinal (diarrhea, nausea and vomiting), musculoskeletal (muscle ache) and neurologic (headache or confusion). More common signs and symptoms are fever (83-98%), cough (76-82%), and short of breath (31-55%).
There were about 15% with fever, cough, and short of breath. 1, 15 Conjunctival injection was not reported in the early series and cases with age under 18 were few. After onset of illness the symptoms are somehow mild and the median time to first hospital admission is 7.0 days (4.0-8.0). But the disease progresses to short of breath (~8 days), acute respiratory distress syndrome (ARDS) (~9 days), and to mechanical ventilation (~10.5 days) in about 39% patients.(1) Patients with fatal disease develop ARDS and worsened in a short period of time and died of multiple organ failure. 1, 15 The mortality rate in the early series of hospitalized patients was 11-15%, but the later statistics was 2-3%. 1, 15, 16, 17 The 2019-nCoV virus may enter the host through respiratory tract or mucosal surfaces (such as conjunctiva). Oral-fecal transmission has not been confirmed. The virus has a preferential tropism to human airway epithelial cells and the cellular receptor, like SARS, is ACE2. 18 However, the pathological changes of the disease and its pathogenesis in human is not clearly elucidated. Theoretically lungs are the major involved organ. Will the virus replicate in other part of the body is not clear.
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5.Diagnosis
The SSCP usually presents as an acute viral respiratory tract infection and many differential diagnoses related to common viral pneumonia should be considered, such as influenza, parainfluenza, adenovirus infection, respiratory syncytial virus infection, metapneumovirus infection, and atypical pathogens, such as mycoplasma pneumoniae and clamydophila pneumoniae infections etc. 1, 8 Therefore, it is crucial to trace the travel and exposure history when approaching a suspected patient back from an epidemic area.
In addition, commercial respiratory syndromic diagnostic kits that detect multiple 
6.Treatment
Currently there is no validated treatment for SSCP. The main strategies are symptomatic and supportive care, such as keeping vital signs, maintaining oxygen saturation and blood pressure, and treating complications, such as secondary infections or organs failure.
Because of the potential mortality of SSCP, many investigational treatments are isopropanol., 0.05% benzalkonium chloride, 1% cresol soap, or hydrogen peroxide (0.5-7.0%) etc. 21 According to the WHO recommendations for Ebola virus (RG4) disinfection, the environment with spills of blood or body fluids could be cleaned up with 1:10 dilution of 5.25% household bleach for 10 minutes. For surfaces that may corrode or discolor, the recommendation was careful cleaning to remove visible stains A C C E P T E D followed by contact with a 1:100 dilution of 5.25% household bleach for more than 10 minutes. 22
8.Conclusions
2019-nCoV infection is a zoonotic disease with low to moderate mortality rate.
Currently, there is no standard treatment for the disease and supportive treatment was the only strategy. Although many experimental trials are on the way, the best we can https://www.who.int/csr/disease/ebola/hand-hygiene/en/. Accessed Feb 7, 2020. The first confirmed nCoV case in Wuhan (no Huanan seafood market exposure) December 10
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The first confirmed nCoV case with Huanan seafood market exposure December 31
An epidemiological alert by local agency 2020 January 1 Huanan seafood market shut down January 13
The first nCoV case in Thailand (Wuhan history) January 15
A notifiable communicable disease (by Taiwan CDC) January 21
The first nCoV case in Taiwan (Wuhan history) January 30
Public health emergencies of international concern (PHEIC) alarm by WHO February 6
28,276 confirmed nCoV cases, 565 deaths, at least 25 countries involved nCoV: novel coronavirus CDC: center of disease control WHO: the World Health Organization
